Birdwatch Note Rating
2024-11-29 03:22:47 UTC - HELPFUL
Rated by Participant: 5ECB710E8A0803E7F71CBF61B2FF81A4CB2D18ABDF9BEE774826148F40928983
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details